(Life News)—A George Soros-backed political action committee (PAC) is launching a multimillion-dollar effort to flip Texas blue, The Wall Street Journal reported Monday.
Democrats haven’t won a statewide election in the Republican stronghold in decades. However, Texas Majority PAC, which has received millions of dollars in funding from Soros, hopes to change that trend with its new “Blue Texas” initiative, according to the WSJ.
Soros and his network of political spending outfits have poured hundreds of millions into supporting Democratic candidates and causes in recent election cycles. Soros donated $2.1 million to Texas Majority PAC in 2024 and $1 million in April, WSJ reported.
The Blue Texas initiative aims to boost candidate recruitment, organize volunteers, and increase voter turnout, with the goal of turning Texas into a battleground state by 2032, according to the WSJ. Texas Majority, along with state and county Democratic parties, spent about $35 million during the 2024 election cycle, and the new initiative’s price tag is expected to surpass that amount.
- Read More: lifenews.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.